Comprehensive Guide to the E613 10 Pill
Everything you need to know about identifying, using, and safely managing the E613 10 pill.
Key Takeaways
- E613 10 is identified as Opana 10 mg, an opioid analgesic.
- Proper usage under medical supervision is crucial due to high addiction and overdose risks.
- Recognizing its appearance helps prevent misuse and ensures appropriate handling.
Overview of E613 10 Pill
The E613 10 pill is recognized as Opana 10 mg, which contains the active ingredient oxymorphone hydrochloride. Opana belongs to the opioid class of medications and is primarily prescribed for managing moderate to severe pain. Due to its potent analgesic properties, it is typically reserved for patients who require continuous, long-term opioid treatment and are opioid-tolerant.
Identification of E613 10 Pill
Accurate identification of the E613 10 pill is essential for both patients and healthcare providers to ensure proper usage and prevent medication errors. The pill has the following characteristics:
| Attribute | Description |
|---|---|
| Imprint | E613 10 |
| Color | Red |
| Shape | Round |
| Size | Approximately 9mm in diameter |
| Manufacturer | Endo Pharmaceuticals Inc. |
| Drug Class | Opioid (Narcotic) Analgesic |
Uses and Indications
Opana (oxymorphone hydrochloride) is prescribed for the management of moderate to severe pain. It is especially indicated for patients who are opioid-tolerant and require continuous, around-the-clock opioid treatment. Opana works by altering the way the brain and nervous system respond to pain, providing effective pain relief when other pain medications may not be sufficient.
Dosage and Administration
The standard dosage of Opana for adults typically starts at 10 mg, taken orally on an empty stomach to enhance absorption. The exact dosage may vary based on individual patient needs, response to treatment, and tolerance levels. It is paramount to follow the healthcare provider's instructions meticulously to minimize risks associated with opioid medications.
Patients should:
- Take the medication exactly as prescribed.
- Avoid increasing the dose or frequency without consulting a healthcare provider.
- Use the lowest effective dose for the shortest duration necessary.
Risks and Precautions
Opana, like other opioids, carries significant risks that necessitate careful consideration and monitoring:
Addiction and Dependence
Opana has a high potential for addiction, abuse, and misuse, which can lead to overdose and death. Patients should be thoroughly evaluated for a history of substance abuse before initiating therapy and should be monitored regularly for signs of addiction.
Respiratory Depression
One of the most serious risks of Opana is respiratory depression, which can be fatal, especially during the initiation of therapy or when doses are increased. Patients should be monitored closely, particularly during the first few days of treatment or when the dose is changed.
Pregnancy and Neonatal Risks
Use of Opana during pregnancy can lead to neonatal opioid withdrawal syndrome, a serious condition requiring specialized treatment. Pregnant women should discuss the risks and benefits with their healthcare provider.
Drug Interactions
Combining Opana with other central nervous system (CNS) depressants, such as alcohol, benzodiazepines, or other opioids, significantly increases the risk of profound sedation, respiratory depression, coma, and death. It is crucial to inform healthcare providers of all medications and supplements being taken to avoid dangerous interactions.
Usage Guidance
Opana should only be used as prescribed by a healthcare provider. It is intended for use in opioid-tolerant patients and is not suitable for those who are not accustomed to opioid therapy. Misuse can lead to severe health consequences, including death.
Side Effects
Like all medications, Opana can cause side effects, which may vary in severity:
Common Side Effects
- Nausea
- Dizziness
- Constipation
- Drowsiness
- Headache
These side effects are generally manageable but should be reported to a healthcare provider if they persist or worsen.
Severe Side Effects
Seek immediate medical attention if you experience:
- Difficulty breathing or shortness of breath
- Extreme drowsiness or inability to stay awake
- Confusion or severe mood swings
- Loss of consciousness
- Serious allergic reactions such as rash, itching, or swelling
These symptoms may indicate a life-threatening reaction requiring urgent care.
Interactions with Other Substances
Opana can interact with various substances, leading to adverse effects. It is essential to be aware of these interactions to ensure safety:
Medications
- Other CNS Depressants: Combining Opana with medications like benzodiazepines, muscle relaxants, or other opioids can enhance sedative effects and increase the risk of respiratory depression.
- MAO Inhibitors: Using Opana with MAO inhibitors (e.g., phenelzine, tranylcypromine) can lead to severe and potentially fatal reactions.
- Anticholinergic Drugs: Concurrent use may increase the risk of severe constipation and gastrointestinal obstruction.
Substances
- Alcohol: Alcohol consumption while taking Opana can potentiate side effects like drowsiness, dizziness, and respiratory depression.
- Tobacco: Smoking can affect the metabolism of opioids, potentially altering their efficacy and the risk of side effects.
Always inform your healthcare provider about all medications and substances you are taking to avoid harmful interactions.
Storage Instructions
Proper storage of Opana is essential to maintain its efficacy and prevent misuse:
-
Temperature: Store at room temperature, away from excessive heat and moisture.
-
Access: Keep the medication out of reach of children and pets to prevent accidental ingestion.
-
Disposal: Dispose of unused or expired medication safely, following local regulations or take-back programs.
Legal Status and Regulation
Opana is classified as a Schedule II controlled substance in the United States, indicating a high potential for abuse and dependence. As such, it is subject to strict regulatory controls regarding its prescription, dispensing, and monitoring. Healthcare providers must adhere to specific guidelines to prevent misuse and diversion of the medication.
Conclusion
The E613 10 pill, identified as Opana 10 mg, is a potent opioid analgesic used to manage moderate to severe pain in opioid-tolerant patients. While it offers effective pain relief, its high potential for addiction, abuse, and severe side effects necessitates cautious use under strict medical supervision. Proper identification, adherence to prescribed dosages, awareness of potential interactions, and secure storage are crucial components in ensuring the safe and effective use of this medication. Patients and caregivers should maintain open communication with healthcare providers to monitor therapy and mitigate risks associated with Opana.
References
Last updated January 23, 2025